BioCentury
ARTICLE | Financial News

Affymetrix meets Street estimate

October 24, 2001 7:00 AM UTC

AFFX reported a third quarter loss of $0.11, in line with consensus estimates. Revenues, which consist primarily of sales of its GeneChip microarrays, came in at $55.4 million - above the $52 million ...